Clinical Trial Update: Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial comparing autologous PRF, 1% alendronate gel, and 1.2% atorvastatin gel for chronic periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Alendronate Gel (1%) (alendronate)
• Atorvastatin gel (1.2%) (atorvastatin)
• Autologous PRF

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Chronic Periodontitis | Phase 2, Phase 3 | Status: COMPLETED